The CYP2D6 Activity Score: Translating Genotype Information into a Qualitative Measure of Phenotype
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Inferring CYP2D6 phenotype from genotype is increasingly challenging, considering the growing number of alleles and their range of activity. This complexity poses a challenge in translational research where genotyping is being considered as a tool to personalize drug therapy. To simplify genotype interpretation and improve phenotype prediction, we evaluated the utility of an "activity score" (AS) system. Over 25 CYP2D6 allelic variants were genotyped in 672 subjects of primarily Caucasian and African-American heritage. The ability of genotype and AS to accurately predict phenotype using the CYP2D6 probe substrate dextromethorphan was evaluated using linear regression and clustering methods. Phenotype prediction, given as a probability for each AS group, was most accurate if ethnicity was considered; among subjects with genotypes containing a CYP2D6*2 allele, CYP2D6 activity was significantly slower in African Americans compared to Caucasians. The AS tool warrants further prospective evaluation for CYP2D6 substrates and in additional ethnic populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kirchheiner, J., Nickchen, K., Bauer, M., Wong, M.-L., Licinio, J., Roots, I., & Brockmöller, J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001494 · Cited by 724
Bertilsson, L., Lou, Y.-Q., Du, Y.-L., Liu, Y., Kuang, T.-Y., Liao, X.-M., Wang, K.-Y., Reviriego, J., Iselius, L., & Sjöqvist, F. (1992) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1992.38 · Cited by 399
Schmid, B., Bircher, J., Preisig, R., & Küpfer, A. (1985) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1985.235 · Cited by 383
Griese, E.-U., Zanger, U. M., Brudermanns, U., Gaedigk, A., Mikus, G., M??rike, K., St??ven, T., & Eichelbaum, M. (1998) · Pharmacogenetics · doi:10.1097/00008571-199802000-00003 · Cited by 283
Self-citationMetabolic Drug Interactions with Newer Antipsychotics: A Comparative Review
Spina, E., & De Leon, J. (2007) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2007.00017.x · Cited by 271
Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6
Zanger, U. M., Fischer, J., Raimundo, S., Stüven, T., Evert, B. O., Schwab, M., & Eichelbaum, M. (2001) · Pharmacogenetics · doi:10.1097/00008571-200110000-00004 · Cited by 266
Gaedigk, A., Gotschall, R. R., Forbes, N. S., Simon, S. D., Kearns, G. L., & Leeder, J. S. (1999) · Pharmacogenetics and Genomics · doi:10.1097/01213011-199912000-00002 · Cited by 181
Self-citationOntogeny of Dextromethorphan O- and N-demethylation in the First Year of Life
Blake, M. J., Gaedigk, A., Pearce, R. E., Bomgaars, L. R., Christensen, M. L., Stowe, C., James, L. P., Wilson, J. T., Kearns, G. L., & Leeder, J. S. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100101 · Cited by 169
Self-citationA Combination of Mutations in the CYP2D6*17(CYP2D6Z) Allele Causes Alterations in Enzyme Function
Oscarson, M., Hidestrand, M., Johansson, I., & Ingelman‐Sundberg, M. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.6.1034 · Cited by 141
Steimer, W., Zöpf, K., von Amelunxen, S., Pfeiffer, H., Bachofer, J., Popp, J., Messner, B., Kissling, W., & Leucht, S. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.030825 · Cited by 141
Corchero, J., Granvil, C. P., Akiyama, T. E., Hayhurst, G. P., Pimprale, S., Feigenbaum, L., Idle, J. R., & Gonzalez, F. J. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1260 · Cited by 140
TATEISHI, T., Chida, M., Ariyoshi, N., et al. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70077-9 · Cited by 117
Cai, W.-M., Nikoloff, D. M., Pan, R. M.-D., de León, J., Fanti, P., Fairchild, M., Koch, W. H., & Wedlund, P. J. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500378 · Cited by 102
The African‐specific CYP2D6*17 allele encodes an enzyme with changed substrate specificity
Wennerholm, A., Dandara, C., Sayi, J., Svensson, J., Abdi, Y. A., Ingelman‐Sundberg, M., Bertilsson, L., Hasler, J. A., & Gustafsson, L. L. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.120239 · Cited by 94
Investigation of terbinafine as a CYP2D6 inhibitor in vivo
ABDELRAHMAN, S., Gotschall, R. R., KAUFFMAN, R., Leeder, J. S., & KEARNS, G. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70065-2 · Cited by 86
Self-citationGaedigk, A., Bhathena, A., Ndjountché, L., Pearce, R. E., Abdel‐Rahman, S. M., Alander, S. W., Bradford, L. D., & Leeder, J. S. (2005) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500305 · Cited by 84
Self-citationGaedigk, A., Ryder, D. L., Bradford, L. D., & Leeder, J. S. (2003) · Clinical Chemistry · doi:10.1373/49.6.1008 · Cited by 72
Self-citationSubstrate specific metabolism by polymorphic cytochrome P450 2D6 alleles
Bogni, A., Monshouwer, M., Moscone, A., Hidestrand, M., Ingelman‐Sundberg, M., Härtung, T., & Coecke, S. (2005) · Toxicology in Vitro · doi:10.1016/j.tiv.2005.04.001 · Cited by 67
Findling, R. L., Nucci, G., Piergies, A. A., Goméni, R., Bartolic, E. I., Fong, R., Carpenter, D. J., Leeder, J. S., Gaedigk, A., & Danoff, T. M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300960 · Cited by 58
Self-citationFunck‐Brentano, C., Boëlle, P., Verstuyft, C., Bornert, C., Becquemont, L., & Poirier, J. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0051-5 · Cited by 55
A leadership crisis in American psychiatry
Licinio, J. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001467 · Cited by 20
Cited by
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446
Hicks, J., Bishop, Jr., Sangkuhl, K., Müller, D., Ji, Y., Leckband, S., Leeder, J., Graham, R., Chiulli, D., LLerena, A., et al. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.147 · Cited by 998
Self-citationPolymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance: Part I
Zhou, S.-F. (2009) · Clinical Pharmacokinetics · doi:10.2165/11318030-000000000-00000 · Cited by 756
Hicks, J., Sangkuhl, K., Swen, J., Ellingrod, V., Müller, D., Shimoda, K., Bishop, Jr., Kharasch, E., Skaar, T., Gaedigk, A., et al. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.597 · Cited by 685
Self-citationCrews, K. R., Gaedigk, A., Dunnenberger, H. M., Leeder, J. S., Klein, T. E., Caudle, K. E., Haidar, C. E., Shen, D. D., Callaghan, J. T., Sadhasivam, S., et al. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.254 · Cited by 680
Self-citation
Metadata
- Authors
- Gaedigk, A., Simon, S., Pearce, R., Bradford, L., Kennedy, M., & Leeder, J.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2007-10-31
- Volume
- 83
- Issue
- 2
- Pages
- 234-242
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2104058573
- Cited by
- 779
- References
- 21
- FWCI
- 24.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.